Indoco Remedies spurts on receiving USFDA nod for Lofexidine tablets

Indoco Remedies gained 4.61% to Rs 350.85 after the firm received final approval from the US Food and Drug administration (USFDA) for its abbreviated new drug application (ANDA) for Lofexidine Tablets.